MUC2 overexpression has repeatedly been demonstrated as a poor prognostic factor for non-digestive system cancers, such as breast cancer, bladder cancer and ovarian cancer, in previous studies [28-30]. This evidence concerns the gene MUC2 and ovarian carcinoma.